Mary Philip

14PUBLICATIONS
57CO-AUTHORS
Solid tumoursHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 06, 2026
TCF1lo CD8 T cells proliferate and persist autonomously in tumors.

Megan M Erwin, Natalie R Favret, Claudia N McDavid

|Nov 24, 2025
Pre-division TCF1 drop determines long-term CD8 T cell fates.

Natalie R Favret, Maider Astorkia, Melissa M Wolf

|Nov 19, 2025
MDR1 promotes CD8 T cell persistence in tumors and protects against cytotoxic chemotherapy.

Lincoln A Brown, Megan M Erwin, Natalie R Favret

|Oct 03, 2024
Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor control.

Carlos R Detrés Román, Megan M Erwin, Michael W Rudloff

|Mar 11, 2024
Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor control.

Carlos R Detrés Román, Michael W Rudloff, Frank Revetta

|Oct 16, 2023
Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1- Dysfunctional State.

Jessica J Roetman, Megan M Erwin, Michael W Rudloff

Pageof 3